-+ 0.00%
-+ 0.00%
-+ 0.00%

Quoin Pharmaceuticals Announces Achieves Target Loading Concentration For Its Two Topical Rapamycin Delivery Technologies.

Benzinga·11/11/2025 13:34:34
Listen to the news

Target Loadings of 4% and 5% Rapamycin Achieved for Topical Lotion and Dermal Patch Delivery Technologies Respectively

Clinical Trial and Stability Batch Manufacture to Commence in Q4 2025

Clinical Testing in a Number of Indications Including Microcystic Lymphatic Malformations and Venous Malformations, among others to Commence 1H 2026